BIOVIDRIA, INC.

TUCSON, AZ · Founded 2007 · Medtech · Private

UHPLC chromatography columns with polymeric bonded phases for native protein separation

Claim this profile

Follows are private to you and power your alerts

Updated

Sector
Medtech
Headquarters
TUCSON, AZ
Founded
2007
Latest Form D
$150K, Jul 2010
Total capital
$991K
Federal grants
$641K
2 awards · 2015–2016
Rank in peer group#119 of 445
Private capital raised
$350K
2 Form D · last Jul 2010
196 months since last filing
Federal contracts
None on recordNo federal contract awards found.
Granted patents
None on recordNo USPTO grants. Applications publish after 18 months.

Capital timeline

20092010201120122013201420152016FEDERAL ↑EQUITY ↓Cumulative $991K$501K$140K1st Form D$200K2nd Form D$150K
2009201120132015FEDERAL ↑EQUITY ↓Cumulative $991K$501K$140K2nd Form D$150K

Latest events

  • Federal grantHealth and Human S · Phase I · Ultrahigh Performance Non-Denaturing Protein Chromatography Columns$140K
  • Federal grantHealth and Human S · Phase II · Slip Flow Chromatography$501K
  • Private capital raisedForm D · SEC · 2nd filing$150K
  • Private capital raisedForm D · SEC · 1st filing$200K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 445 peers

Line = median

Medtech · Device

  • Federal grants#119 · top 27%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

Researcher links verified by same-company patents and grants
  • Mary J WirthResearcherExecutive Officer, DirectorLinked by $641K in grants as PI
  • Albert P StathamExecutive Officer, DirectorNamed in SEC Form D filings
  • Corey M SmithExecutive Officer, DirectorNamed in SEC Form D filings
  • Gabriel LongoriaDirectorNamed in SEC Form D filings
  • Kirt J GardnerDirectorNamed in SEC Form D filings

What it has protected

No granted patents are on record.

USPTO usually publishes applications 18 months after filing, so recent applications may not be visible yet. Patents assigned under a different entity name won’t match.

Checked: USPTO granted patents and published applications · Oct 23, 2026

  • Fluxus, Inc.Similar federal contract value in Medtech · null in contracts
  • ENCLEAR THERAPIES, INC.Similar federal contract value in Medtech · null in contracts
  • APC AVE 20, LLCSimilar federal contract value in Medtech · null in contracts
  • NOVASTERILIS, INC.Similar federal contract value in Medtech · null in contracts
  • VIC FOUNDRY INCSimilar federal contract value in Medtech · null in contracts
  • Revelle Aesthetics, Inc.Similar federal contract value in Medtech · null in contracts

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .